Asahi Kasei Corp 2024 IR
The report outlines Asahi Kasei's strategic progress under its medium-term management plan 'Be a Trailblazer' and its three-sector management model spanning Material, Homes, and Health Care. Key developments include a 180 billion yen investment to construct a Hipore lithium-ion battery separator plant in Canada and the acquisition of Calliditas Therapeutics to strengthen its global specialty pharma business. In sustainability, the company reduced its Scope 1 and Scope 2 greenhouse gas emissions by 38% compared to fiscal 2013 and achieved its RE100 goal ahead of schedule.
Company: Asahi Kasei Corp
Sector: Manufacturing
Country: Japan
Year: 2024
Type: IR
Pages: 104
Back to company
Asahi Kasei Corp
Corporate Report
The report outlines Asahi Kasei's strategic progress under its medium-term management plan 'Be a Trailblazer' and its three-sector management model spanning Material, Homes, and Health Care. Key developments include a 180 billion yen investment to construct a Hipore lithium-ion battery separator plant in Canada and the acquisition of Calliditas Therapeutics to strengthen its global specialty pharma business. In sustainability, the company reduced its Scope 1 and Scope 2 greenhouse gas emissions by 38% compared to fiscal 2013 and achieved its RE100 goal ahead of schedule.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Apr 1, 2023 - Mar 31, 2024
Fiscal Year
2023
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Net Zero Target
Employees